Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in NASH
NCT01208649Phase 4Completed
- Sponsor
- Ruhr University Bochum
- Start
- Jul 2008
- Primary completion
- Sep 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in Nonalcoholic steatohepatitis (NASH), sponsored by Ruhr University Bochum. Started Jul 2008; status: completed.
02
Drugs
exenatide
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01208649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208649.